Cargando…
Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants
We developed a spatially structured, fully stochastic, individual-based SARS-CoV-2 transmission model to evaluate the feasibility of sustaining SARS-CoV-2 local containment in mainland China considering currently dominant Omicron variants, China’s current immunization level, and non-pharmaceutical i...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128785/ https://www.ncbi.nlm.nih.gov/pubmed/35611330 http://dx.doi.org/10.1101/2022.05.07.22274792 |
_version_ | 1784712618216259584 |
---|---|
author | Wang, Yan Sun, Kaiyuan Feng, Zhaomin Yi, Lan Wu, Yanpeng Liu, Hengcong Wang, Quanyi Ajelli, Marco Viboud, Cécile Yu, Hongjie |
author_facet | Wang, Yan Sun, Kaiyuan Feng, Zhaomin Yi, Lan Wu, Yanpeng Liu, Hengcong Wang, Quanyi Ajelli, Marco Viboud, Cécile Yu, Hongjie |
author_sort | Wang, Yan |
collection | PubMed |
description | We developed a spatially structured, fully stochastic, individual-based SARS-CoV-2 transmission model to evaluate the feasibility of sustaining SARS-CoV-2 local containment in mainland China considering currently dominant Omicron variants, China’s current immunization level, and non-pharmaceutical interventions (NPIs). We also built a statistical model to estimate the overall disease burden under various hypothetical mitigation scenarios. We found that due to high transmissibility, neither Omicron BA.1 or BA.2 could be contained by China’s pre-Omicron NPI strategies which were successful prior to the emergence of the Omicron variants. However, increased intervention intensity, such as enhanced population mobility restrictions and multi-round mass testing, could lead to containment success. We estimated that an acute Omicron epidemic wave in mainland China would result in significant number of deaths if China were to reopen under current vaccine coverage with no antiviral uptake, while increasing vaccination coverage and antiviral uptake could substantially reduce the disease burden. As China’s current vaccination has yet to reach high coverage in older populations, NPIs remain essential tools to maintain low levels of infection while building up protective population immunity, ensuring a smooth transition out of the pandemic phase while minimizing the overall disease burden. |
format | Online Article Text |
id | pubmed-9128785 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-91287852022-05-25 Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants Wang, Yan Sun, Kaiyuan Feng, Zhaomin Yi, Lan Wu, Yanpeng Liu, Hengcong Wang, Quanyi Ajelli, Marco Viboud, Cécile Yu, Hongjie medRxiv Article We developed a spatially structured, fully stochastic, individual-based SARS-CoV-2 transmission model to evaluate the feasibility of sustaining SARS-CoV-2 local containment in mainland China considering currently dominant Omicron variants, China’s current immunization level, and non-pharmaceutical interventions (NPIs). We also built a statistical model to estimate the overall disease burden under various hypothetical mitigation scenarios. We found that due to high transmissibility, neither Omicron BA.1 or BA.2 could be contained by China’s pre-Omicron NPI strategies which were successful prior to the emergence of the Omicron variants. However, increased intervention intensity, such as enhanced population mobility restrictions and multi-round mass testing, could lead to containment success. We estimated that an acute Omicron epidemic wave in mainland China would result in significant number of deaths if China were to reopen under current vaccine coverage with no antiviral uptake, while increasing vaccination coverage and antiviral uptake could substantially reduce the disease burden. As China’s current vaccination has yet to reach high coverage in older populations, NPIs remain essential tools to maintain low levels of infection while building up protective population immunity, ensuring a smooth transition out of the pandemic phase while minimizing the overall disease burden. Cold Spring Harbor Laboratory 2022-06-06 /pmc/articles/PMC9128785/ /pubmed/35611330 http://dx.doi.org/10.1101/2022.05.07.22274792 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. |
spellingShingle | Article Wang, Yan Sun, Kaiyuan Feng, Zhaomin Yi, Lan Wu, Yanpeng Liu, Hengcong Wang, Quanyi Ajelli, Marco Viboud, Cécile Yu, Hongjie Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants |
title | Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants |
title_full | Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants |
title_fullStr | Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants |
title_full_unstemmed | Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants |
title_short | Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants |
title_sort | assessing the feasibility of sustaining sars-cov-2 local containment in china in the era of highly transmissible variants |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128785/ https://www.ncbi.nlm.nih.gov/pubmed/35611330 http://dx.doi.org/10.1101/2022.05.07.22274792 |
work_keys_str_mv | AT wangyan assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants AT sunkaiyuan assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants AT fengzhaomin assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants AT yilan assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants AT wuyanpeng assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants AT liuhengcong assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants AT wangquanyi assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants AT ajellimarco assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants AT viboudcecile assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants AT yuhongjie assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants |